Prenatal Cannabinoid Exposure
Prenatal Cannabinoid Exposure - Related Videos
11:01
Moderate Prenatal Alcohol Exposure and Quantification of Social Behavior in Adult Rats
0 Views •
Cited by 20 •
2014
The goal of the protocol presented here is to describe procedures to expose rats to moderate levels of alcohol during prenatal brain development and to quantify resulting alterations in social behavior during adulthood.
10:27
Isolation and Culture of Hippocampal Neurons from Prenatal Mice
0 Views •
Cited by 183 •
2012
We provide a protocol for the culture of highly purified hippocampal neurons from prenatal mouse brains without the use of a feeder glial cell layer.
05:13
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
0 Views •
Cited by 1 •
2025
As legislative restrictions change, resulting in increased accessibility of cannabinoid products, it is critically important to develop models to study the impact of these exposures, particularly during pregnancy. A preclinical model of moderate prenatal cannabinoid exposure through voluntary ingestion has been developed, enabling more in-depth investigations.
02:31
Detection of Orexin and Cannabinoid Receptor Co-localization in Diet-Induced Obese Zebrafish
0 Views •
2025
This video demonstrates a protocol for investigating the co-localization of orexin and cannabinoid receptors in normal and diet-induced obesity (DIO) adult zebrafish brain tissue using immunofluorescence.
01:24
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
0 Views •
2024
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
FAQs
Placental transfer allows cannabinoids to reach the fetal environment, where THC and related compounds may interact with cannabinoid receptors. These receptors are part of the endocannabinoid system, which contributes to neurodevelopment, growth, and placental function. Because those processes are biologically important during pregnancy, receptor-level interactions provide a mechanistic basis for studying possible developmental and birth-related outcomes.
The endocannabinoid system acts as a signaling network involved in several processes relevant to pregnancy, including neurodevelopment, growth, and placental function. Cannabinoids can interact with cannabinoid receptors within this system, making receptor signaling an important focus of medical research. This framework helps researchers connect maternal exposure with biological processes without assuming that every observed outcome has a single cause.
Timing, dose, and route of administration help characterize how exposure occurred and are therefore important variables in risk assessment. Different patterns of maternal cannabis use may not represent the same fetal exposure conditions. Considering these factors allows researchers to describe exposure more precisely and supports more careful interpretation of findings related to development, behavior, and birth outcomes.
Researchers characterize exposure by examining maternal cannabis use together with the route of administration, timing during pregnancy, and dose. They also account for coexisting factors that may influence interpretation, including tobacco use and socioeconomic conditions. This structured approach helps distinguish exposure patterns from surrounding circumstances and provides a stronger basis for evaluating potential developmental, behavioral, and birth-related outcomes.
Tobacco use and socioeconomic conditions can coexist with maternal cannabis use, so they are important context when researchers evaluate observed outcomes. Accounting for these factors helps prevent exposure findings from being interpreted without considering other relevant circumstances. In medicine, this broader assessment supports more balanced risk evaluation and improves the usefulness of evidence for prenatal counseling.
Medical research on prenatal cannabinoid exposure informs counseling by organizing evidence around exposure timing, dose, route, and potentially influential coexisting factors. It also examines developmental, behavioral, and birth outcomes rather than focusing on a single endpoint. These considerations help clinicians discuss available evidence carefully and support individualized risk assessment while ongoing studies continue to investigate longer-term implications.